CRISPR-based genome editing in disease treatment

Trends Mol Med. 2023 Aug;29(8):673-674. doi: 10.1016/j.molmed.2023.05.003. Epub 2023 May 31.

Authors

Huan Qin¹, Weihui Xu¹, Kai Yao²

Affiliations

¹ Institute of Visual Neuroscience and Stem Cell Engineering, Wuhan University of Science and Technology, Wuhan, China.
² Institute of Visual Neuroscience and Stem Cell Engineering, Wuhan University of Science and Technology, Wuhan, China. Electronic address: kyao21@outlook.com.

PMID: 37263857
DOI: 10.1016/j.molmed.2023.05.003

No abstract available

Keywords: CRISPR; base editing; genome editing; prime editing.

MeSH terms

CRISPR-Cas Systems*
Gene Editing*
Humans